KELSEY BODELL: Open Payments
NPI 1215585237 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 52 payments from 13 companies in 2025. Trend: 2023 $923 · 2024 $1,347 · 2025 $934
Food & beverage: $832Education: $102
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $185 |
| UCB, Inc. | 11 | $164 |
| ABBVIE INC. | 10 | $164 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Lilly USA, LLC | 3 | $75 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Incyte Corporation | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Organon LLC | 3 | $21 |
Products named: DUPIXENT, Bimzelx, TALTZ, Zoryve, QULIPTA, UBRELVY, OPZELURA, SKYRIZI.
Industry payments across OH — which companies pay providers there.
